The $300 Billion Patent Cliff
1:48–2:41 · 53s
Lou quantifies the looming revenue loss from expiring patents and explains why giants like Eli Lilly are spraying cash into acquisitions to diversify fast.
1:48–2:41 · 53s
Lou quantifies the looming revenue loss from expiring patents and explains why giants like Eli Lilly are spraying cash into acquisitions to diversify fast.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.